Technology
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will…
University of Sydney will use AI to boost cancer drug research
The University of Sydney and Australian company Pharos Therapeutics have reached an agreement to leverage artificial intelligence (AI) to progress…
Sun rises on Lithuania’s life sciences industry
Lithuania possesses one of the oldest languages still in use today, a tree which is amongst the most ancient in…
ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit
The Institute of Cancer Research (ICR), along with its hospital partner The Royal Marsden NHS Foundation Trust, has opened a…
Sanofi deploys Veeva Systems’ solutions to improve quality management
Pharmaceutical company Veeva Systems has announced that Sanofi is implementing its solutions to improve the latter’s quality management process. The…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Recursion plans $87.5m acquisitions to shore up AI drug discovery
Recursion Pharmaceuticals announced it has entered into agreements to acquire two drug chemistry-focused preclinical startups, Cyclica and Valance, for a…
Click Therapeutics kicks off digital therapy remote trial for migraine
Click Therapeutics announced the initiation of a fully remote trial investigating the potential of digital therapeutics to reduce migraine occurrences…
Breathing easy: How digital inhalers are changing asthma treatment
AstraZeneca, Teva Pharmaceuticals, and Novartis, and other companies, are expanding their reach in the asthma space by capitalizing on digital…
3BP and Novartis strike licensing agreement for FAP-targeting peptide technology
German biotechnology firm 3B Pharmaceuticals (3BP) has entered into a licensing agreement with Novartis Innovative Therapies for its fibroblast activation…
Covid-19 vaccine success bolsters nanoparticle drug delivery research
In 1974, Dr. Robert Langer was part of the first cohort of researchers to begin nanoparticle research, as his lab…